Back
Xeris Biopharma Holdings Stock Price Chart
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.
Buy
59
XERS
Xeris Biopharma Holdings
Last Price:
$4.38
Seasonality Move:
-6.65%
7 Day Trial
ALL ACCESS PASS
$
7
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XERS is experiencing slight selling pressure.
Xeris Biopharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.64 | Sell |
| 20-day SMA: | 4.78 | Sell |
| 50-day SMA: | 4.61 | Sell |
| 200-day SMA: | 3.73 | Buy |
| 8-day EMA: | 4.61 | Sell |
| 20-day EMA: | 4.69 | Sell |
| 50-day EMA: | 4.62 | Sell |
| 200-day EMA: | 3.86 | Buy |
Xeris Biopharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 46 | Sell |
| Chaikin Money Flow: | -217045 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.55 - 5.01) | Sell |
| Bollinger Bands (100): | (3.67 - 5.03) | Buy |
Xeris Biopharma Holdings Technical Analysis
| May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Xeris Biopharma Holdings Stock
Is Xeris Biopharma Holdings Stock a Buy?
-
Xeris Biopharma Holdings share price is 4.55 while XERS 8-day simple moving average is 4.64, which is a Sell signal.
-
The stock price of XERS is 4.55 while Xeris Biopharma Holdings 20-day SMA is 4.78, which makes it a Sell.
-
Xeris Biopharma Holdings 50-day simple moving average is 4.61 while XERS share price is 4.55, making it a Sell technically.
-
XERS stock price is 4.55 and Xeris Biopharma Holdings 200-day simple moving average is 3.73, creating a Buy signal.
XERS Technical Analysis vs Fundamental Analysis
Buy
59
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy or a Sell?
-
Xeris Biopharma Holdings stock is rated a BuyThe current Xeris Biopharma Holdings [XERS] share price is $4.55. The Score for XERS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Xeris Biopharma Holdings Stock Info
Market Cap:
728.7M
Price in USD:
4.55
Share Volume:
2M
Xeris Biopharma Holdings 52-Week Range
52-Week High:
6.07
52-Week Low:
2.03
Buy
59
Xeris Biopharma Holdings (XERS)
is a Buy
Xeris Biopharma Holdings Share Price Forecast
-
What is the Xeris Biopharma Holdings stock price today?The Xeris Biopharma Holdings stock price is 4.55 USD today.
-
Will XERS stock go up or go down?Xeris Biopharma Holdings> share price is forecast to RISE/FALL based on technical indicators
-
Is Xeris Biopharma Holdings overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xeris Biopharma Holdings is not overvalued.
Is Xeris Biopharma Holdings Stock a Buy?
-
Xeris Biopharma Holdings share price is 4.55 while XERS 8-day exponential moving average is 4.61, which is a Sell signal.
-
The stock price of XERS is 4.55 while Xeris Biopharma Holdings 20-day EMA is 4.69, which makes it a Sell.
-
Xeris Biopharma Holdings 50-day exponential moving average is 4.62 while XERS share price is 4.55, making it a Sell technically.
-
XERS stock price is 4.55 and Xeris Biopharma Holdings 200-day simple moving average is 3.86, creating a Buy signal.
Fundamental Analysis of Xeris Biopharma Holdings
Is Xeris Biopharma Holdings a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.16 per share, and an increase next year of $0.01 per share.
Technical Analysis of Xeris Biopharma Holdings
Should I short Xeris Biopharma Holdings stock?
-
XERS Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Xeris Biopharma Holdings is a Sell
-
Xeris Biopharma Holdings Relative Strength Index (RSI) is 46, which suggest Xeris Biopharma Holdings is oversold
-
The Bollinger Bands (25) for Xeris Biopharma Holdings is (4.55 - 5.01), which suggest Xeris Biopharma Holdings is a Buy
-
The Bollinger Bands (100) for Xeris Biopharma Holdings is (3.67 - 5.03), which suggest Xeris Biopharma Holdings is a Buy
* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.